Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Year in Review 2024 - Top Clinical Trials in Sarcoma

Oncology 2024 Year in Review

R. Jones

Year in Review 2024 - Updates in Precision Oncology in Sarcomas

Oncology 2024 Year in Review

E. Nassif Haddad

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

2024 ESMO Annual Meeting Insights Hub

R. Jones

Afami-Cel TCR for Sarcoma

Moffitt Cancer Center

B. Van Tine

Sarcoma Insights: Types, Diagnosis, and Treatment Approaches

Total Health

M. Orians, D. Portnoy

EA7222: Phase 3 Trial of Doxorubicin ± Pembro for Undifferentiated P…

Seth Pollack

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

2024 ASCO® Annual Meeting Insights Hub

A. Hussein

ASCO® 2024 Highlights in Sarcomas

2024 ASCO® Annual Meeting Insights Hub

R. Jones

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Total Health

B. Wilky

2024 Update in Sarcomas

Total Health

D. Portnoy

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Precision Oncology in the Diagnosis and Management of Sarcoma

University of Miami Sylvester Comprehensive Cancer Center

S. Bialick

2025 Updates in Surgical Principles for 1L & Relapsed Uterine Sarcoma

Jalid Sehouli

NCCN Clinical Practice Guidelines for Treating GIST

Andrea Napolitano

Efficacy of Nirogacestat in Desmoid Tumors With Poor Prognostic Fact…

Bruno Vincenzi

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

Warren Chow

Sarcoma Panel Discussion: Molecular Tumor Board - Multidisciplinary …

University of Miami Sylvester Comprehensive Cancer Center

P. Seo, A. Rosenberg, P. Castillo, M. De La Fuente, S. Gultekin, E. Krill-Jackson, C. Gomez

Divide and Conquer Sarcomas Through Precision Oncology

Miami Cancer Institute Precision Oncology Symposium

N. Somaiah